vita

Biologics

Josh SandbergJune 1, 2011
771

Orthovita shareholders sue to stop $316 million Stryker buyout

Shareholders of Orthovita Inc. (NSDQ: VITA), a Malvern, Pa.-based orthopedic biologics maker, are suing over a proposed $316 million merger by…
Read More »
Josh SandbergMay 31, 2011
732

Stryker Launches Tender Offer

Orthopedic devices giant Stryker Corp (SYK – Analyst Report) has commenced its $3.85 per share tender offer for its previously announced acquisition…
Read More »
Josh SandbergDecember 9, 2010
901

Orthovita Gets FDA Clearance for Vitoss Bioactive Foam-2X Bone Graft Substitute

Orthovita, Inc., an orthobiologics and biosurgery company, said that it received 510(k) clearance from the U.S. Food and Drug Administration…
Read More »